1. Johnston SA. Osteoarthritis. Joint anatomy, physiology, and pathobiology. Vet Clin North Am Small Anim Pract 1997; 27:699–723.
2. Fox SM, Millis D. Osteoarthritis: the disease. In: Multimodal management of canine osteoarthritis. London: Manson Publishing Ltd, 2010; 24–30.
3. Veterinary Pet Insurance. Nation's largest pet insurer reveals most common causes of veterinary visits. Available at: press.petinsurance.com/pressroom/02222011Pet_Conditions_2010.aspx. Accessed Jun 15, 2012.
4. Textor J. Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein. Vet Clin North Am Equine Pract 2011; 27:275–298.
5. Fortier LA, Barker JU, Strauss EJ, et al. The role of growth factors in cartilage repair. Clin Orthop Relat Res 2011; 469:2706–2715.
6. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. Phys Med Rehabil 2011; 3:226–250.
7. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006; 14:403–412.
8. Kajikawa Y, Morihara T, Sakamoto H, et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 2008; 215:837–845.
9. van den Dolder J, Mooren R, Vloon AP, et al. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 2006; 12:3067–3073.
10. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011; 27:1490–1501.
11. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011; 19:528–535.
12. Cook JL, Evans R, Conzemius MG. Proposed definitions and criteria for reporting time frame, outcome and complications for clinical orthopedic studies in veterinary medicine. Vet Surg 2010; 39:905–908.
13. The CONSORT Group. The CONSORT Statement. Available at: www.consort-statement.org/consort-statement/overview0/. Accessed Jun 15, 2012.
14. Hudson JT, Slater MR, Taylor L, et al. Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs. Am J Vet Res 2004; 65:1634–1643.
15. University of Pennsylvania School of Veterinary Medicine Veterinary Clinical Investigations Center. Canine Brief Pain Inventory. Available at: research.vet.upenn.edu/PennChart/AvailableTools/tabid/1969/Default.aspx. Accessed Jun 15, 2012.
16. Brown DC, Boston RC, Coyne JC, et al. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc 2008; 233:1278–1283.
17. Brown DC, Boston RC, Coyne JC, et al. Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res 2007; 68:631–637.
18. Allen GS. Radiographic signs of joint disease in dogs and cats. In: Thrall D, ed. Textbook of veterinary diagnostic radiology. 5th ed. St Louis: Saunders Elsevier, 2007; 317–358.
19. Innes JF, Costello M, Barr FJ, et al. Radiographic progression of osteoarthritis of the canine stifle joint: a prospective study. Vet Radiol Ultrasound 2004; 45:143–148.
20. Fox SM, Millis D. Multimodal management of canine osteoarthritis. London: Manson Publishing Ltd, 2010; 96.
21. Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc 2007; 230:514–521.
22. Beraud R, Moreau M, Lussier B. Effect of exercise on kinetic gait analysis of dogs afflicted by osteoarthritis. Vet Comp Orthop Traumatol 2010; 23:87–92.
23. KuKanich B, Bidgood T, Knesl O. Clinical pharmacology of nonsteroidal anti-inflammatory drugs in dogs. Vet Anaesth Analg 2012; 39:69–90.
24. Vandeweerd JM, Coisnon C, Clegg P, et al. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. J Vet Intern Med 2012; 26:448–456.
25. Hjermstad MJ, Fayers PM, Haugen DF, et al. European Palliative Care Research Collaborative (EPCRC). Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 2011; 41:1073–1093.
26. Hielm-Björkman AK, Kapatkin AS, Rita HJ. Reliability and validity of a visual analogue scale used by owners to measure chronic pain attributable to osteoarthritis in their dogs. Am J Vet Res 2011; 72:601–607.
27. Budsberg SC, Jevens DJ, Brown J, et al. Evaluation of limb symmetry indices, using ground reaction forces in healthy dogs. Am J Vet Res 1993; 54:1569–1574.
28. DeCamp CE, Soutas-Little RW, Hauptman J, et al. Kinematic gait analysis of the trot in healthy Greyhounds. Am J Vet Res 1993; 54:627–634.
29. Rumph PF, Lander JE, Kincaid SA, et al. Ground reaction force profiles from force platform gait analyses of clinically normal mesomorphic dogs at the trot. Am J Vet Res 1994; 55:756–761.
30. Bennett RL, DeCamp CE, Flo GL, et al. Kinematic gait analysis in dogs with hip dysplasia. Am J Vet Res 1996; 57:966–971.
31. Budsberg SC, Chambers JN, Lue SL, et al. Prospective evaluation of ground reaction forces in dogs undergoing unilateral total hip replacement. Am J Vet Res 1996; 57:1781–1785.
32. Budsberg SC, Johnston SA, Schwarz PD, et al. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. J Am Vet Med Assoc 1999; 214:206–210.
33. Al-Nadaf S, Torres BT, Budsberg SC. Comparison of two methods for analyzing kinetic gait data in dogs. Am J Vet Res 2012; 73:189–193.
34. Budsberg SC, Torres BT, Zwijnenber RJ, et al. Effect of perzinfotel and a proprietary phospholipase A(2) inhibitor on kinetic gait and subjective lameness scores in dogs with sodium urate-induced synovitis. Am J Vet Res 2011; 72:757–763.
35. Imhoff DJ, Gordon-Evans WJ, Evans RB, et al. Evaluation of S-adenosyl L-methionine in a double-blinded, randomized, placebo-controlled, clinical trial for treatment of presumptive osteoarthritis in the dog. Vet Surg 2011; 40:228–232.
36. Oosterlinck M, Bosmans T, Gasthuys F, et al. Accuracy of pressure plate kinetic asymmetry indices and their correlation with visual gait assessments scores in lame and nonlame dogs. Am J Vet Res 2011; 72:820–825.
37. Ishihara A, Bertone AL, Rajala-Schultz PJ. Association between subjective lameness grade and kinetic gait parameters in horses with experimentally induced forelimb lameness. Am J Vet Res 2005; 66:1805–1815.
38. Dohan Ehrenfest DM, Bielecki T, Del Corso M, et al. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A 2010; 95:1280–1282.
39. Boswell SG, Cole BJ, Sundman EA, et al. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 2012; 28:429–439.
40. Bielecki T, Dohan Ehrenfest DM, Everts PA, et al. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: new perspectives. Curr Pharm Biotechnol 2012; 13:1153–1162.
41. Dragoo JL, Braun HJ, Durham JL, et al. comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med 2012; 40:1274–1281.
42. Trowbridge CC, Stammers AH, Woods E, et al. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol 2005; 37:381–386.
43. Forsberg-Nilsson K, Behar TN, Afrakhte M, et al. Platelet-derived growth factor induces chemotaxis of neuroepithelial stem cells. J Neurosci Res 1998; 53:521–530.
44. Lee JM, Kim BS, Lee H, et al. In vivo tracking of mesenchymal stem cells using fluorescent nanoparticles in an osteochondral repair model. Mol Ther 2012; 20:1434–1442.
Advertisement
Objective—To determine efficacy of a single intra-articular injection of an autologous platelet concentrate for treatment of osteoarthritis in dogs.
Design—Randomized, controlled, 2-center clinical trial.
Animals—20 client-owned dogs with osteoarthritis involving a single joint.
Procedures—Dogs were randomly assigned to a treatment or control group. In all dogs, severity of lameness and pain was scored by owners with the Hudson visual analog scale and the University of Pennsylvania Canine Brief Pain Inventory, respectively, and peak vertical force (PVF) was determined with a force platform. Dogs in the treatment group were then sedated, and a blood sample (55 mL) was obtained. Platelets were recovered by means of a point-of-use filter and injected intra-articularly within 30 minutes. Control dogs were sedated and given an intra-articular injection of saline (0.9% NaCl) solution. Assessments were repeated 12 weeks after injection of platelets or saline solution.
Results—Dogs weighed between 18.3 and 63.9 kg (40.3 and 140.6 lb) and ranged from 1.5 to 8 years old. For control dogs, lameness scores, pain scores, and PVF at week 12 were not significantly different from pretreatment values. In contrast, for dogs that received platelet injections, lameness scores (55% decrease in median score), pain scores (53% decrease in median score), and PVF (12% increase in mean PVF) were significantly improved after 12 weeks, compared with pretreatment values.
Conclusions and Clinical Relevance—Results suggested that a single intra-articular injection of autologous platelets resulted in significant improvements at 12 weeks in dogs with osteoarthritis involving a single joint.
Supported in part by the Pall Corp.
Presented in abstract form at the 39th Annual Congress of the Veterinary Orthopedic Society, Crested Butte, Colo, March 2012; and at the American College of Veterinary Surgeons Annual Symposium, National Harbor, Md, October 2012.
The authors thank Dr. Akikazu Ishihara for data compilation; Nicole Stingle for study coordination; Dr. Marc Togneri, Dr. David Clark, and Kimberly Holt for study participation; and Dr. Michael P. Kowaleski for serving as a scientific advisor.